Anaplastic Lymphoma Kinase Is Required for Neurogenesis in the Developing Central Nervous System of Zebrafish
Sheng Yao(BioReliance (United States)), Christoph Winkler(National University of Singapore)
Cited by 79
Related Papers
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
Research progress in polylactic acid processing for 3D printing
|Journal of Manufacturing Processes|2024|110
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial
|Signal Transduction and Targeted Therapy|2021|94
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors
|Cancer Communications|2020|54